<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of the Russian academy of medical sciences</journal-id><journal-title-group><journal-title xml:lang="en">Annals of the Russian academy of medical sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российской академии медицинских наук</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-6047</issn><issn publication-format="electronic">2414-3545</issn><publisher><publisher-name xml:lang="en">"Paediatrician" Publishers LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1369</article-id><article-id pub-id-type="doi">10.15690/vramn1369</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>OBSTETRICS AND GYNAECOLOGY: CURRENT ISSUES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ВОПРОСЫ АКУШЕРСТВА И ГИНЕКОЛОГИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The Role of Extracellular Vesicles of Various Origins in the Development of Preeclampsia</article-title><trans-title-group xml:lang="ru"><trans-title>Роль экстраклеточных везикул различного происхождения в развитии преэклампсии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9459-5698</contrib-id><contrib-id contrib-id-type="scopus">57191960907</contrib-id><contrib-id contrib-id-type="researcherid">AAI-6271-2020</contrib-id><contrib-id contrib-id-type="spin">8295-9290</contrib-id><name-alternatives><name xml:lang="en"><surname>Nikolaeva</surname><given-names>Mariya G.</given-names></name><name xml:lang="ru"><surname>Николаева</surname><given-names>Мария Геннадьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Associate Professor</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, доцент кафедры акушерства и гинекологии с курсом ДПО</p></bio><email>nikolmg@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0695-6145</contrib-id><contrib-id contrib-id-type="spin">9359-1428</contrib-id><name-alternatives><name xml:lang="en"><surname>Terekhina</surname><given-names>Vasilisa U.</given-names></name><name xml:lang="ru"><surname>Терехина</surname><given-names>Василиса Юрьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>assistant</p></bio><bio xml:lang="ru"><p>ассистент кафедры акушерства и гинекологии с курсом ДПО</p></bio><email>vasutka_07@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0967-6117</contrib-id><contrib-id contrib-id-type="scopus">37102157300</contrib-id><contrib-id contrib-id-type="researcherid">AAB-8493-2020</contrib-id><contrib-id contrib-id-type="spin">6231-4604</contrib-id><name-alternatives><name xml:lang="en"><surname>Kudinov</surname><given-names>Alexey V.</given-names></name><name xml:lang="ru"><surname>Кудинов</surname><given-names>Алексей Владимирович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>candidate of biological sciences</p></bio><bio xml:lang="ru"><p>кандидат биологических наук, старший научный сотрудник</p></bio><email>kudinovalexej@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8413-5484</contrib-id><contrib-id contrib-id-type="scopus">6603848680</contrib-id><contrib-id contrib-id-type="researcherid">M-7923-2015</contrib-id><contrib-id contrib-id-type="spin">8464-9030</contrib-id><name-alternatives><name xml:lang="en"><surname>Momot</surname><given-names>Andrey P.</given-names></name><name xml:lang="ru"><surname>Момот</surname><given-names>Андрей Павлович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор</p></bio><email>xyzan@yandex.ru</email><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Altai State Medical University</institution></aff><aff><institution xml:lang="ru">Алтайский Государственный медицинский Университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">National Research Center for Hematology</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр гематологии</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Altai State Medical University</institution></aff><aff><institution xml:lang="ru">Алтайский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">National Medical Research Center for Hematology</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр гематологии</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-09-03" publication-format="electronic"><day>03</day><month>09</month><year>2021</year></pub-date><volume>76</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>237</fpage><lpage>243</lpage><history><date date-type="received" iso-8601-date="2020-06-07"><day>07</day><month>06</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-05-03"><day>03</day><month>05</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, "Paediatrician" Publishers LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Издательство "Педиатръ"</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">"Paediatrician" Publishers LLC</copyright-holder><copyright-holder xml:lang="ru">Издательство "Педиатръ"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-09-03"/></permissions><self-uri xlink:href="https://vestnikramn.spr-journal.ru/jour/article/view/1369">https://vestnikramn.spr-journal.ru/jour/article/view/1369</self-uri><abstract xml:lang="en"><p>Pre-eclampsia is a clinically unfavorable pregnancy outcome that determines the main indicators of maternal and/or perinatal morbidity and mortality. According to modern concepts, the placenta plays a central role in the development of PE, while intercellular and intervesicular communications involving extracellular vesicles (EVs, extracellular vesicles) initiate a cascade of various biological effects, determining the mechanisms of ontogenesis of the gestational process in normal and pathological conditions. Achievements in studies of extracellular vesicles (EVs, extracellular vesicles) are of particular interest both to clinicians and to researchers studying the pathophysiology of gestational complications. Extracellular vesicles (EVs) in preeclampsia are produced both by scintiotrophoblast and the maternal body - blood cells (platelets, red blood cells, white blood cells) and the cardiovascular (vascular endothelium, smooth muscle) system. Changes in the concentration of these EVs can contribute to the implementation of preeclampsia, enhancing the pro-inflammatory and procoagulant states inherent in the gestation process. This review focuses on freely available information on the possible interactions between placental and maternal EVs. Understanding the contribution of EVs to the development of preeclampsia can help to deepen knowledge about the pathogenesis of this pathology and determine the diagnostic and prognostic significance of extracellular vesicles as biomarkers.</p></abstract><trans-abstract xml:lang="ru"><p>Преэклампсия – это клинически неблагоприятный исход беременности, определяющий основные показатели материнской и/ или перинатальной заболеваемости и смертности. Согласно современным представлениям, центральная роль в развитии преэклампсии принадлежит плаценте, при этом межклеточные и межвезикулярные коммуникации с участием экстраклеточных везикул (extracellular vesicles, EVs) инициируют целый каскад различных биологических эффектов, определяя механизмы онтогенеза гестационного процесса в норме и патологии. Экстраклеточные везикулы (EVs) при преэклампсии вырабатываются как синцитиотрофобластом, так и материнским организмом — клетками кровеносной (тромбоциты, эритроциты, лейкоциты) и сердечно-сосудистой (эндотелий сосудов, гладкомышечная мускулатура) систем. Изменения концентрации этих EVs в плазме крови, могут способствовать реализации преэклампсии, усиливая провоспалительные и прокоагулянтные состояния, свойственные процессу гестации. В настоящем обзоре основное внимание уделяется имеющейся в свободном доступе информации о возможных взаимодействиях между EVs плацентарного и материнского происхождения, а также о влиянии EVs различного происхождения на гемостатический баланс. Понимание вклада EVs в развитие преэклампсии может способствовать углублению знаний о ее патогенезе и определить диагностическую и прогностическую значимость экстраклеточных везикул в качестве биомаркеров.</p></trans-abstract><kwd-group xml:lang="en"><kwd>extracellular vesicles</kwd><kwd>preeclampsia</kwd><kwd>scintiotrophoblast</kwd><kwd>tissue factor</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>экстраклеточные везикулы</kwd><kwd>преэклампсия</kwd><kwd>синцитиотрофобласт</kwd><kwd>тканевой фактор</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>La Rocca C, Carbone F, Longobardi S, Matarese G. The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus. Immunol Lett. 2014;162(1):41–48. doi: https://doi.org/10.1016/J.IMLET.2014.06.013</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Clemmens H, Lambert DW. Extracellular vesicles: Translational challenges and opportunities. Biochem Soc Trans. 2018;46(5):1073–1082. doi: https://doi.org/10.1042/BST20180112</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Pieragostino D, Lanuti P, Cicalini I, et al. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis. J Proteom. 2019;204:103403. doi: https://doi.org/10.1016/j.jprot.2019.103403</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Grande R, Dovizio M, Marcone S, et al. Platelet-Derived Microparticles from Obese Individuals: Characterization of Number, Size, Proteomics, and CrosstalkWith Cancer and Endothelial Cells. Front Pharmacol. 2019;10:7. doi: https://doi.org/10.3389/fphar.2019.00007</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Jaiswal R, Sedger LM. Intercellular Vesicular Transfer by Exosomes, Microparticles and Oncosomes — Implications for Cancer Biology and Treatments. Front Oncol. 2019;9:125. doi: https://doi.org/10.3389/fonc.2019.00125</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Willms E, Cabañas C, Mäger I, et al. Extracellular Vesicle Heterogeneity: Subpopulations, Isolation Techniques, and Diverse Functions in Cancer Progression. Front Immunol. 2018;9:738. doi: https://doi.org/10.3389/fimmu.2018.00738</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Kakarla R, Hur J, Kim YJ, et al. Apoptotic cell-derived exosomes: Messages from dying cells. Exp Mol Med. 2020;52(1):1–6. doi: https://doi.org/10.1038/s12276-019-0362-8</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750. doi: https://doi.org/10.1080/20013078.2018.1535750</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Klein-Scory S, Tehrani MM, Eilert-Micus C, et al. New insights in the composition of extracellular vesicles from pancreatic cancer cells: Implications for biomarkers and functions. Proteome Sci. 2014;12(1):50. doi: https://doi.org/10.1186/s12953-014-0050-5</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Кубатиев А.А., Боровая Т.Г., Жуковицкая В.Г., и др. Микрочастицы тромбоцитов: образование и свойства // Патогенез. — 2017. — Т. 15. — № 2. — С. 4–13. [Kubatiev AA, Borovaya TG, ZHukovickaya VG, i dr. Mikrochasticy trombocitov: obrazovanie i svojstva. Patogenez. 2017;15(2):4–13. (In Russ.)] doi: https://doi.org/10.25557/GM.2017.2.7296</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Пантелеев М.А., Абаева А.А., Баландина А.Н., и др. Внеклеточные везикулы плазмы крови: состав, происхождение, свойства // Биологические мембраны. — 2017. — Т. 34. — № 3. — С. 155–161. [Panteleev MA, Abaeva AA, Balandina AN, i dr. Vnekletochnye vezikuly plazmy krovi: sostav, proiskhozhdenie, svojstva. Biologicheskie Membrany. 2017;34(3):155–161. (In Russ.)] doi: https://doi.org/10.7868/S0233475517030069</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Керкешко Г.О., Кореневский А.В., Соколов Д.И., Сельков С.А. Роль взаимодействия экстраклеточных микровезикул трофобласта с клетками иммунной системы и эндотелия в патогенезе преэклампсии // Медицинская иммунология. — 2018. — Т. 20. — № 4. — С. 485–514. [Kerkeshko GO, Korenevskij AV, Sokolov DI, Sel’kov SA. Rol’ vzaimodejstviya ekstrakletochnyh mikrovezikul trofoblasta s kletkami immunnoj sistemy i endoteliya v patogeneze preeklampsii. Medicinskaya Immunologiya. 2018;20(4):485–514. (In Russ.)] doi: https://doi.org/10.15789/1563-0625-2018-4-485-514</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Marques FK, Campos FM, Filho OA, et al. Circulating microparticles in severe preeclampsia. Clin Chim Acta. 2012;24(414):253–258. doi: https://doi.org/10.1016/j.cca.2012.09.023</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Mikhailova VA, Ovchinnikova OM, Zainulina MS, et al. Detection of microparticles of leukocytic origin in the peripheral blood in normal pregnancy and preeclampsia. Bull Exp Biol Med. 2014;157(6):751– 756. doi: https://doi.org/10.1007/s10517-014-2659-x</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Salomon C, Guanzon D, Scholz-Romero K, et al. Placental Exosomes as Early Biomarker of Preeclampsia: Potential Role of Exosomal MicroRNAs Across Gestation. J Clin Endocrinol Metab. 2017;102;3182–3194. doi: https://doi.org/10.1210/jc.2017-00672</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Zhang Y, Zhao C, Wei Y, et al. Increased circulating microparticles in women with preeclampsia. Int J Lab Hematol. 2018;40(3):352–358. doi: https://doi.org/10.1111/ijlh.12796</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>McElrath TF, Cantonwine DE, Gray KJ, et al. Late first trimester circulating microparticle proteins predict the risk of preeclampsia &lt; 35 weeks and suggest phenotypic differences among affected cases. Sci Rep. 2020;10(1):17353. doi: https://doi.org/10.1038/s41598-020-74078-w</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Goswami D, Tannetta DS, Magee LA, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta. 2006;27(1):56–61. doi: https://doi.org/10.1016/j.placenta.2004.11.007</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Verma S, Pillay P, Naicker T, et al. Placental hypoxia inducible factor-1α &amp; CHOP immuno-histochemical expression relative to maternal circulatory syncytiotrophoblast micro-vesicles in preeclamptic and normotensive pregnancies. Eur J Obstet Gynecol Reprod Biol. 2018;220:18–24. doi: https://doi.org/10.1016/j.ejogrb.2017.11.004</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Jadli A, Ghosh K, Damania K, et al. Prediction of preeclampsia using combination of biomarkers at 18–23 weeks of gestation: A nested case-control study. Pregnancy Hypertens. 2019;17:20–27. doi: https://doi.org/10.1016/j.preghy.2019.04.006</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Campello E, Spiezia L, Radu CM, et al. Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia. Thromb Res. 2015;136(2):427–431. doi: https://doi.org/10.1016/j.thromres.2015.05.029</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Lok CA, Nieuwland R, Sturk A, et al. Microparticle-associated P-selectin reflects platelet activation in preeclampsia. Platelets. 2007;18(1):68–72. doi: https://doi.org/10.1080/09537100600864285</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Kohli S, Ranjan S, Hoffmann J, et al. Maternal extracellular vesicles and platelets promote preeclampsia via inflammasome activation in trophoblasts. Blood. 2016;128(17):2153–2164. doi: https://doi.org/10.1182/blood-2016-03-705434</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Faas MM, de Vos P. Maternal monocytes in pregnancy and preeclampsia in humans and in rats. J Reprod Immunol. 2017;119:91–97. doi: https://doi.org/10.1016/j.jri.2016.06.009</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol. 2011;31:27–33. doi: https://doi.org/10.1161/ATVBAHA.110.218123</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Petrozella L, Mahendroo M, Timmons B, et al. Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period. Am J Obstet Gynecol. 2012;20(2):140.e20–6. doi: https://doi.org/10.1016/j.ajog.2012.06.011</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Perez-Gonzalez R, Gauthier SA, Kumar A, et al. The exosome secretory pathway transports amyloid precursor protein carboxyl-terminal fragments from the cell into the brain extracellular space. J Biol Chem. 2012;287(51):43108–43115.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Schmorl G. Pathologisch-anatomischeuntersuchungenuber puerperal-eklampsie (pathological and anatomical examinations of puerperal-eclampsia). Leipzig: FCW Vogel; 1893:106.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Chua S, Wilkins T, Sargent I, Redman C. Trophoblast deportation in pre-eclamptic pregnancy. Br J Obstet Gynaecol. 1991;98(10):973–979. doi: https://doi.org/10.1111/j.1471-0528.1991.tb15334.x</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Ikle FA. Dissemination of syncytial trophoblastic cells in the maternal blood stream during pregnancy. Bull Schweiz Akad Med Wiss. 1964;20:62–72.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Милованов А.П., Волощук И.Н. Депортированный синцитиотрофобласт и плацентарные микрочастицы в организме матери при нормальной беременности и преэклампсии (28 лет спустя) // Архив патологии. — 2017. — Т. 79. — № 1. — С. 61–67. [Milovanov AP, Voloshchuk IN. Deportirovannyj sincitiotrofoblast i placentarnye mikrochasticy v organizme materi pri normal’noj beremennosti i preeklampsii (28 let spustya). Arhiv Patologii. 2017;79(1):61–67. (In Russ.)] doi: https://doi.org/10.17116/patol201779161-67</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Tannetta DS, Hunt K, Jones CI, et al. Syncytiotrophoblast extracellular vesicles from preeclampsia placentas differentially affect platelet function. PLoS One. 2015;10(11):e0142538. doi: https://doi.org/10.1371/journal.pone.0142538</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Salomon C, Torres MJ, Kobayashi M, et al. A gestational profile of placental exosomes in maternal plasma and their effects on endothelial cell migration. PLoS One. 2014;9(6):e98667. doi: https://doi.org/10.1371/journal.pone.0098667</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Morgan TK. Cell- and size-specific analysis of placental extracellular vesicles in maternal plasma and pre-eclampsia. Transl Res. 2018;201:40–48. doi: https://doi.org/10.1016/j.trsl.2018.08.004</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Motta-Mejia C, Kandzija N, Zhang W, et al. Placental Vesicles Carry Active Endothelial Nitric Oxide Synthase and Their Activity is Reduced in Preeclampsia. Hypertension. 2017;70:372–381. doi: https://doi.org/10.1161/HYPERTENSIONAHA.117.09321</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Takov K, He Z, Johnston HE, et al. Small extracellular vesicles secreted from human amniotic fluid mesenchymal stromal cells possess cardioprotective and promigratory potential. Basic Res Cardiol. 2020;115:26. doi: https://doi.org/10.1007/s00395-020-0785-3</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Collett GP, Redman CW, Sargent IL, Vatish M. Endoplasmic reticulum stress stimulates the release of extracellular vesicles carrying danger-associated molecular pattern (DAMP) molecules. Oncotarget. 2018;9(6):6707–6717. doi: https://doi.org/10.18632/oncotarget.24158</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Leung DN, Smith SC, To KF, et al. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 2001;184(6):1249–1250. doi: https://doi.org/10.1067/mob.2001.112906</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Pillay P, Maharaj N, Moodley J, Mackraj I. Placental exosomes and pre-eclampsia: Maternal circulating levels in normal pregnancies and, early and late onset pre-eclamptic pregnancies. Placenta. 2016;46:18–25.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Lau SY, Barrett CJ, Guild SJ, Chamley LW. Necrotic trophoblast debris increases blood pressure during pregnancy. J Reprod Immunol. 2013;97(2):175–182. doi: https://doi.org/10.1016/j.jri.2012.12.005</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Zhang L, Wang Y, Liao AH. Quantitative abnormalities of fetal trophoblast cells in maternal circulation in preeclampsia. Prenat Diagn. 2008;28(12):1160–1166. doi: https://doi.org/10.1002/pd.5521</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Orozco AF, Jorgez CJ, Ramos-Perez WD, et al. Placental release of distinct DNA-associated microparticles into maternal circulation: reflective of gestation time and preeclampsia. Placenta. 2009;30(10):891–897. doi: https://doi.org/10.1016/j.placenta.2009.06.012</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Baig S, Kothandaraman N, Manikandan J, et al. Proteomic analysis of human placental syncytiotrophoblast microvesicles in preeclampsia. Clin Proteomics. 2014;11(1):40. doi: https://doi.org/10.1186/1559-0275-11-40</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Hausvater A, Giannone T, Sandoval Y-HG, Doonan RJ, Antonopoulos CN, Matsoukis IL, Petridou ET, Daskalopoulou SS. The association between preeclampsia and arterial stiffness. J Hypertens. 2012;30:17–33. doi: https://doi.org/10.1097/HJH.0b013e32834e4b0f</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Gill M, Motta-Mejia C, Kandzija N, et al. Placental Syncytiotrophoblast-Derived Extracellular Vesicles Carry Active NEP (Neprilysin) and Are Increased in Preeclampsia. Hypertension. 2019;73(5):1112–1119. doi: https://doi.org/10.1161/HYPERTENSIONAHA.119.12707</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Sokolov DI, Ovchinnikova OM, Korenkov DA, et al. Influence of peripheral blood microparticles of pregnant women with preeclampsia on the phenotype of monocytes. Transl Res. 2016;170:112–123. doi: https://doi.org/10.1016/j.trsl.2014.11.009</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Nair S, Salomon C. Extracellular vesicles and their immunomodulatory functions in pregnancy. Semin Immunopathol. 2018;40:425–437. doi: https://doi.org/10.1007/s00281-018-0680-2</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Holder BS, Jones T, Sancho Shimizu V, et al. Macrophage exosomes induce placental inflammatory cytokines: a novel mode of maternal-placental messaging. Traffic. 2016;17:168–178. doi: https://doi.org/10.1111/tra.12352</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Southcombe J, Tannetta D, Redman C, Sargent I. The immunomodulatory role of syncytiotrophoblast microvesicles. PLoS One. 2011;6:e20245. doi: https://doi.org/10.1371/journal.pone.0020245</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Janes SL, Goodall AH. Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy. Clin Sci (Lond). 1994;86(6):731–739. doi: https://doi.org/10.1042/cs0860731</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Chang X, Yao J, He Q, et al. Exosomes from Women with Preeclampsia Induced Vascular Dysfunction by Delivering sFlt (Soluble Fms-Like Tyrosine Kinase)-1 and sEng (Soluble Endoglin) to Endothelial Cells. Hypertension. 2018;72(6):1381–1390. doi: https://doi.org/10.1161/HYPERTENSIONAHA.118.11706</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Xiao X, Xiao F, Zhao M, et al. Treating normal early gestation placentae with preeclamptic sera produces extracellular micro and nano vesicles that activate endothelial cells. J Reprod Immunol. 2017;120:34–41. doi: https://doi.org/10.1016/j.jri.2017.04.004</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Момот А.П. Физиологическая беременность как модель несостоявшегося тромбоза // Акушерство и гинекология Санкт-Петербурга. — 2017. — № 2. — С. 44–52. [Momot AP. Fiziologicheskaya beremennost’ kak model’ nesostoyavshegosya tromboza. Akusherstvo i Ginekologiya Sankt-Peterburga. 2017;2:44–52. (In Russ.)]</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Lacroix R, Dignat George F. Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation. Thromb Res. 2012;129(2):27–29. doi: https://doi.org/10.1016/j.thromres.2012.02.025</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Khaspekova SG, Antonova OA, Shustova ON, et al. Activity of Tissue Factor in Microparticles Produced in vitro by Endothelial Cells, Monocytes, Granulocytes, and Platelets. Biochemistry. 2016;81(2):114–121. doi: https://doi.org/10.1134/S000629791602005X</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Vallier L, Cointe S, Lacroix R, et al. Microparticles and fibrinolysis. Semin Thromb Hemost. 2017;43:129–134. Epub 2016 Dec 6. doi: https://doi.org/10.1055/s-0036-1592301</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Han C, Wang C, Chen Y, et al. Placenta-derived extracellular vesicles induce preeclampsia in mouse models. Haematologica. 2020; 105(6):1686–1694. doi: https://doi.org/10.3324/haematol.2019.226209</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Aharon A, Katzenell S, Tamari T, Brenner B. Microparticles bearing tissue factor and tissue factor pathway inhibitor in gestational vascular complications. J Thromb Haemost. 2009;7(6):1047–1050. doi: https://doi.org/10.1111/j.1538-7836.2009.03342.x</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Szotowski B, Antoniak S, Poller W, et al. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res. 2005;96:1233–1239. doi: https://doi.org/10.1161/01.RES.0000171805.24799.fa</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Gardiner C, Tannetta DS, Simms CA, et al. Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity. PloS One. 2011;6(10):e26313. doi: https://doi.org/10.1371/journal.pone.0026313.</mixed-citation></ref></ref-list></back></article>
